HYBRID EVENT: You can participate in person at Boston, Massachusetts, USA or Virtually from your home or work.
Baruch Itzhak, Speaker at Diabetes Conferences
Tel Aviv University, Israel
Title : Heart failure management; a perspective from diabetes care


People with type 2 diabetes (T2DM) are recognized as having a 2–4 times increased risk of heart failure (HF). Ambulatory diabetes care has long concentrated on the prevention of microvascular and arterial disease, and surveillance for manageable problems such as with the feet and retinae. Accordingly, management of heart failure has never been a specific focus, although the preventative management of cardiac and kidney disease through glucose-lowering, blood pressure (BP) control, and blood lipid control, have had a positive impact on its incidence. Indeed, the very complexity of routine diabetes care, and its enormous prevalence, has generally excluded the management of any of the advanced late complications, whether cardiac, arterial, retinal, renal, or neurodegenerative. Furthermore, advances in HF management itself, in diagnostics, medications, and technology, has carried it deeper into the remit of specialist cardiological care. More recently and in addition to medications already routinely used in diabetes care such as renin-angiotensin system (RAS) blockers, some glucose-lowering therapies such as sodium glucose transporter inhibitors 2 (SGLT-2 inhibitors), have been found to have very positive effects on hospitalization for HF, indeed even in people who do not have T2DM. Here, from the perspective of the diabetologist, we review the clinical scenario of ambulatory diabetes care, in regard of how HF prevention and management should fit in to clinical practice


Dr. Baruch Itzhak is a specialist in Family Medicine and Diabetologist at Clalit Health Services; Haifa district; Israel.  He was graduated from medicine at Tel-Aviv University in 1986. He received his medical degree in Family Medicine at the Technion faculty of medicine, Haifa in 1994.
Dr. Itzhak is working as a clinician and diabetologist in primary care settings of Clalit Health Services in Israel. He is recognized as a teacher for medical students and residents in Family Medicine and Diabetes, and the project coordinator for ' Diabetes Education and Quality Assurance in the Community.
He is a member of the Israel Association of Family Physicians, Israel National Diabetes council, and the Israel Diabetes Association, and is involved in national projects for Diabetes and its Prevention. He is an active member of the D& CVD study group and PCDE.  
Dr. Itzhak is a clinical investigator in Diabetes, Lipids and Hypertension Research Unit, Lin Medical Center, where he is involved in multiple clinical studies. His special interest is in the prevention of Diabetes and its complications, early initiation, and intensification of Insulin therapy among primary care health providers. He has published articles related to Diabetes in primary care. He is an active speaker in national and international conferences and has participated in many advisory panels.